Abstract
It has been clear since the time of Ehrlich that the greater part of the CNS is not stained when Trypan blue is injected into the blood stream, even when other organs of the body are very heavily stained.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Goldmann EE: Vitalfarbung am Zentralnervensystem. Eimer, Berlin 1913
Pardridge WM, Oldendorf WH, Cancilla P, Frank HL: Blood-brain barrier: Interface between internal medicine and the brain. Ann Intern Med 1986 (105):82–95
Hauw JJ, Lefauconnier JM: La barrière hématoencéphalique. I-Données morphologiques. Rev Neurol (Paris) 1983 (139):611–624
Lefauconnier JM, Hauw JJ: La barrière hématoencéphalique. II-Données physiologiques. Rev Neurol (Paris) 1984 (140):3–13
Lefauconnier JM, Hauw JJ: La barrière hématoencéphalique. III-Données physiologiques. Rev Neurol (Paris) 1984 (140):89–109
Brightman MW, Klatzo I, Olsson Y, Reese TS: The blood-brain barrier to proteins under normal and pathological conditions. J Neurol Sci 1970 (10):215–239
Olsson Y: Vascular permeabilty in the peripheral nervous system. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds) Peripheral Neuropathy, Vol 1. WB Saunders Co, Philadelphia, 1984 pp 579–597
Reese TS, Karnovsky MJ: Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol 1967 (34):207–217
Sternberger NH, Sternberger LA: Blood-brain barrier protein recognized by monoclonal antibody. Proc Natl Acad Sci 1987 (84):8169–7173
Cordon-Cardo C, O’Brien JP, Casals D, Rittman Grauer L, Briedler JL, Melamed MR, Bertino JR: Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 1989 (86):695–698
Abott NJ: Glia and the blood-brain barrier. Nature 1987(325):195
Stewart PA, Wiley MJ: Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: A study using quail-chick transplantation chimeras. Dev Biol 1981 (84):183–192
Janzer RC, Raff MC: Astrocytes induced blood brain barrier properties in endothelial cells. Nature 1987(325):253–257
Raichle ME, Hartman BK, Eichling JO, Sharpe LG: Central noradrenergic regulation of cerebral blood flow and vascular permeability. Proc Natl Acad Sci 1975 (72):3726–3730
Tengvar C, Petterson CAV, Mohammed AK, Olsson Y: Effects of the noradrenalin neurotoxin N-2 chloroethyl-2-bromo-benzylamine hydrochloride (DSP 4) on the blood-brain barrier: An experimental study in the mouse using protein tracer and density determination techniques. Acta Neuropathol 1979 (78):28–34
Harik I: Blood-brain barrier sodium/potassium pump: Modulation by central noradrenergic innervation. Proc Natl Acad Sci USA 1986 (83):4067–4070
Estrada C, Hamed E, Krause DN: Biochemical evidence for cholinergic innervation of intracerebral blood vessels. Brain Research 1983 (266):261–270
Felgenhauer K: The blood-brain barrier redefined. J Neurol 1986 (233):193–194
Broadwell RD, Balin BJ, Salcman M: Transcytotic pathway for blood-borne protein through the blood brain barrier. Proc Natl Acad Sci USA 1988 (85):632–636
Bradbury M: The concept of a blood-brain barrier. John Wiley & sons, Chichester 1979
Raichle ME, Eichling JO, Grubb RL: Brain permeability of water. Arch Neurol 1974 (30):319–321
Walker RW, Cairncross JG, Posner JB: Cerebral herniation in patients receiving cisplatin. J Neuro Oncol 1988 (6):61–65
Wasterlain CG, Posner JB: Cerebral edema in water intoxication: I. Clinical and chemical observations. Arch Neurol 1968 (19):71–78
Holliday MA, Kalayci MN, Harrah J: Factors that limit brain volume changes in response to acute and sustained hyper and hyponatremia. J Clin Investig 1968 (47):1916–1928
Betz AL: Transport of ions across the blood-brain barrier. Federation Proc 1986 (45):2050–2054
Harik SI, Gravina SA, Kalaria RN: Glucose transporter of the blood-brain barrier and brain in chronic hyperglycemia. J Neurochem 1988 (51 ):1930–1936
Kalaria RN, Gravina SA, Schmidley JW, Perry G, Harik SI: The glucose transporter of the human brain and blood-brain barrier. Ann Neurol 1988 (24)757–764
Cremer JE, Ray DE, Sarna GS, Cunningham VJ: A study of the kinetic behaviour of glucose based on simultaneous estimates of influx and phosphorylation in brain regions of rats in different physiological states. Brain Res 1981 (221):331–342
Gjedde A, Crone C: Blood-brain glucose transfer: repression in chronic hyperglycemia. Science 1981 (214):456–457
Pardridge WM, Choi TB: Neutral amino acid transport at the human blood-brain barrier. Federation Proc 1986 (45):2073–2078
Hawkins AR: Transport of essential nutrients across the blood-brain barrier of individual structures. Federation Proc 1986 (45):2055–2059
Hargreaves KM, Pardridge WM: Neutral amino acid transport at the blood-brain barrier. J Biol Chem 1988 (263) :19392–19397
Rechtand E, Rapoport SI: Regulation of the microenvironment of peripheral nerve: Role of the blood-nerve barrier. Prog Neurobiol 1987 (28):303–343
Olsson Y, Reese TS: Inaccessibility of the endoneurium of mouse sciatic nerve to exogenous proteins. Anat Rec 1969 (163):319–325
Storm AJ, Van der Kogel AJ, Nooter K: Effect of X-irradiation on the pharmacokinetics of methotrexate ion rats: Alteration of the blood-brain barrier. Eur J Cancer Clin Oncol 1985 (21):759–764
Greig NH, Momma S, Sweeney DJ, Smith QR, Rapoport SI: Facilitated transport of melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system. Cancer Res 1987 (47):1571–1576
Blasberg RG, Groothuis DR, Wright DC, Molnar P: Drug delivery to brain tumors: physiological and pharmacokinetic aspects of chemotherapy. In: Walker MD, Thomas DGT (eds) Biology of Brain tumour. Martinus Nijhoff Publishers, Boston 1986 pp 211–220
Groothuis DR, Blasberg RG: Rational brain tumor chemotherapy. The interaction of drug and tumor. Neurol Clinics 1985 (3):801–816
Levin VA: Clinical anticancer pharmacology: Some pharmacokinetics considerations. Cancer Treat Rep 1986 (13):61–76
Goldstein GW, Betz AL: Blood vessels and the blood-brain barrier. In: Asburry AK, McKhann GM, McDonald Wl (eds) Diseases of the Nervous System. William Heinemann Medical Books, London 1986 pp 172–184
Shapiro WR, Voorhies RM, Hiesiger EM, Sher PB, Basler GA, Lipschutz LE: Pharmacokinetics of tumor cell exposure to 14C-methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood tumor barriers in rat brain tumors: A quantitative autoradiographic study. Cancer Res 1988 (48):694–701
Hiesiger EM, Basler GA, Lipschutz L, Shapiro WR: Quantitative autoradiographic (QAR) determination of 14C-PCNU concentration in C6 rat glioma after intracarotid administration. Proc Am Ass Cancer Res 1985 (26):349
Stillman MJ, Lipschutz L, Sher P, Ohnishi T, Shapiro WR: Pharmacokinetics of 195mPt-cisplatin entry into experimental rat brain tumors as measured by quantitative autoradiography. Proc Am Ass Cancer Res 1986 (27):408
Rottenberg DA, Dhawan AJL, Cooper SC, Strother N, Alcock N, Ginos JZ: Assessment of the pharmacologic advantage of intra-arterial versus intravenous chemotherapy using 13N-cisplatin and positron emission tomography: Neurology 1987 (37) Suppl 1: 335
Burger PC, Kamenar E, Schold SC, Fay JW, Phillips GL, Herzig GP: Encephalomyelopathy following high-dose BCNU therapy. Cancer 1981 (48):1318–1327
Oldendorf WH: A comparison of carotid and venous injection of antitumor agent BCNU. Trans Am Neurol Assoc 1975 (100): 225–226
Levin VA, Kabra PM, Freeman-Dove MA: Pharmacokinetics of intracarotid artery 14C-BCNU in the squirrel monkey. J Neurosurg 1978 (48):587–593
Shapiro WR, Green SB: Re-evaluating the efficacy of intra-arterial BCNU. J Neurosurg 1987 (66):313–315
Chan PH, Longar S, Fischman RA: Protective effects of liposome-entrapped superoxide dismutase on posttraumatic brain edema. Ann Neurol 1987 (21):540–547
Greer M: Carrier drugs. Neurology 1988 (38):628–632
Reulen HJ: Vasogenic brain edema: New aspects in its formation, resolution and therapy. Br J Anaesth 1976 (48):741–752
Tengvar C: Extensive intraneuronal spread of horseradish peroxidase from a focus of vasogenic edema into remote areas of central nervous system. Acta Neuropathol 1986 (71):177–189
Stewart PA, Hayakawa K, Farrell CL, Del Maestro RF: Quantitative study of microvessel ultrastructure in human peritumoral brain tissue: evidence for a blood-brain barrier defect. J Neurosurg 1987 (67):697–705
Vick NA: Brain tumor microvasculature. In: Weiss L, Gilbert HA, Posner JB (eds) Brain metastases. GK Hall & Co, Boston 1980 pp 115–133
Stewart PA, Hayakawa K, Hayakawa E, Farrell CL, Del Maestro RF: A quantitative study of blood-brain barrier permeability ultrastructure in a new rat glioma model. Acta Neuropathol 1985 (67):96–102
Blasberg R, Molnar P, Groothuis D, Patlak C, Owens E, Fenstermacher J: Concurrent measurements of blood flow and transcapillary transport in avian sarcoma virus-induced experimental brain tumors: Implications for chemotherapy. J Pharmacol Exp Therap 1984 (231):724–735
Molnar P, Blasberg RG, Horowitz M, Smith B, Fenstermacher J: Regional blood-to-tissue transport in RT-9 brain tumors. J Neurosurg 1983 (58):874–884
Levin VA, Freeman-Dove M, Landahl HD: Permeability characteristics of brain adjacent to tumors in rats. Arch Neurol 1975 (32):785–791
Jarden JO, Dhawan V, Poltorak A, Posner JB, Rottenberg DA: Positron emission tomographic measurement of blood-to-brain and blood-to-tumor transport of 82Rb : The effect of dexamethasone and whole-brain radiation therapy. Ann Neurol 1985 (18):636–646
Dvorak HF: Tumors: wounds that do not heal: Similarities between tumor stroma generation and wound healing. New Engl J Med 1986 (315):1650–1659
Ohnishi T, Shapiro WR: Increased capillary in brain produced by a soluble factor from experimental brain tumors: Possible role in cerebral edema. Proc Am Assoc Cancer Res 1987 (28):68
Bruce JN, Criscuolo GR, Merrill MJ: Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasone. J Neurosurg 1987 (67):880–884
Criscuolo GR, Merrill MJ, Oldfield EH: Further characterization of maligant glioma-derived vascular permeability factor. J Neurosurg 1988 (69):254–262
Wahl M, Unterberg A, Baethmann A, Schilling L: Mediators of blood-brain barrier dysfunction and formation of vasogenic edema. J Cereb Blood Flow Metabol 1988 (8):621–634
Shapiro WR: A model for brain metastases. In: Weiss L, Gilbert HA, Posner JB (eds) Brain metastases. GK Hall & Co, Boston 1980 pp 134–145
Ushio Y, Chernik NL, Shapiro WR, Posner JB: Metastatic tumor of the brain: Development of an experimental model. Ann Neurol 1977 (2):20–29
Ushio, Posner JB, Shapiro WR: Chemotherapy of experimental meningeal carcinomatosis. Cancer Res 1977 (37):1232–1237
Ushio Y, Chernik NL, Posner JB, Shapiro WR: Meningeal carcinomatosis: development of an experimental model. J Neuropathol Exp Neurol 1977(36):224–244
Hasegawa H, Allen JC, Mehta BM, Shapiro WR, Posner JB: Enhancement of CNS penetration of methotrexate by hyperosmolar intracarotid mannitol or carcinomatous meningitis. Neurology 1979 (29):1280–1286
Jaeckle KA, Krol G, Posner JB: Evolution of computed tomographic abnormalities in leptomeningeal metastases. Ann Neurol 1985 (17):85–89
Sze G: MRI of tumor metastases to the leptomeninges. MRI Decisions 1988 (2):2–8
Ushio Y, Posner R, Posner JB et al: Experimental spinal cord compression caused by epidural neoplasms. Neurology 1977 (27):422–429
Delattre J-Y, Arbit E, Thaler HT, Rosenblum MK, Posner JB: A dose-response study of dexamethasone in a model of spinal cord compression caused by epidural tumor. J Neurosurg 1989 (70):920–925
Levin VA, Edwards MS, Byrd A: Quantitative observations of the acute effects of x-irradiation on brain capillary permeability. Int J Radiat Oncol Biol Phys 1979 (5):1627–1631
Phillips PC, Delattre J-Y, Berger CA, Rottenberg DA: Early and progressive increase in regional brain capillary permeability following single-and fractionated-dose cranial radiation in the rat. Neurology 1987 (37) suppl 1:301
Delattre J-Y, Shapiro WR, Posner JB: Acute effects of low-dose cranial irradiation on regional capillary permeability in experimental brain tumors. J Neurol Sciences 1989 (90):147–153
Delattre J-Y, Rosenblum MK, Thaler HT, Mandell L, Shapiro WR: A model of radiation myelopathy in the rat: pathology, regional capillary permeability changes and treatment with dexamethasone. Brain 1988 (111):1319–1336
Devinsky O, Lemann W, Evans AC, Moeller JR, Rottenberg DA: Akinetic mutism in a bone marrow transplant recipient following total-body irradiation and amphotericin B chemoprophylaxis. A positron emission tomographic and neuropathology study. Arch Neurol 1987 (44):414–417
Neuwelt EA, Glasberg M, Frenkel E, Barnett P: Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: Neuropathological studies. Ann Neurol 1983 (14):316–324
Neuwelt EA, Pagel M, Barnett P, Glassberg M, Frenkel EP: Pharmacology and toxicity of intracarotid adriamycin administration following osmotic blood-brain barrier disruption. Cancer Res 1981 (41):4466–4471
Neuwelt EA, Barnett PA, Glasberg M, Frenkel EP: Pharmacology and neurotoxicity of cisdiaminedichloroplatinum, bleomycin, 5-fluorouracil and cyclophosphamide administration following osmotic blood-brain barrier modification. Cancer Res1983(43):5278–5285
Neuwelt EA, Barnett PA, Bigner DD, Frenkel EP: Effects of adrenal cortical steroids and osmotic blood-brain opening on methotrexate delivery to gliomas in the rodent: The factor of the blood-brain barrier. Proc Natl Acad Sci 1982 (79):4420–4423
Tomiwa K, Hazama F, Mikawa H: Neurotoxicity of vincristine after the osmotic opening of the blood brain barrier. J Neuropathol Appl Neurobiol 1983 (9):345–354
Phillips PC, Dhawan V, Strother SC, Sidtis JJ, Evans AC, Allen JC, Rottenberg DA: Reduced cerebral glucose metabolism and increased brain capillary permeability following high-dose methotrexate chemotherapy: A positron emission tomographic study. Ann Neurol 1987 (21):59–63
Hollis PH, Zappulla RA, Spigelman MK, Feuer EJ, Johnson J, Holland JF, Malis LI: Physiological and electrophysiological consequences of etoposide induced blood-brain barrier disruption. Neurosurgery 1986 (18):581–586
Spigelman MK, Zapulla RA, Strauchen JA, Feuer EJ, Johnson J, Goldsmith SJ, Malis LI, Holland JF: Etoposide induced blood-brain barrier disruption in rats: Duration of opening and histological sequelae. Cancer Res 1986 (46):1453–1457
Alexander JT, Saris SC, Oldfield EH: The effect of interleukin-2 on the blood-brain barrier in the 9L gliosarcoma rat model. J Neurosurg 1989 (70):92–96
Watts RG, Wright JL, Atkinson LL, Merchant RE: Histopathological and blood-brain barrier changes in rats induced by an intracerebral injection of human recombinant interleukin 2. Neurosurg 1989 (25):202–208
Ellison MD, Povlishock, Merchant RE : Blood-brain barrier dysfunction in cats following recombinant interleukin-2 infusion. Cancer Res 1987 (47):5765–5770
Hedley-White ET, Hsu DW: Effect of dexamethasone on blood-brain barrier in the normal mouse. Ann Neurol 1986 (19):373–377
Reid AC, Teasdale GM, McCulloch J: The effects of dexamethasone administration and withdrawal on water permeability across the blood-brain barrier. Ann Neurol 1983 (13):28–31
Ziylan YZ, LeFauconnier JM, Bernard G, Bourre JM: Effect of dexamethasone on transport of alpha-aminoisobutyric acid and sucrose across the blood-brain barrier. J Neurochem 1988 (51):1338–1342
Long JB, Holaday JW: Blood-brain barrier: endogenous modulation by adrenal cortical function. Science 1985 (227):1580–1583
Eisenberg HM, Barlow CF, Lorenzo AV: Effect of dexamethasone on altered brain vascular permeability. Arch Neurol 1970 (23):18–22
Galicich JH, French LA, Melby JC: Use of dexamethasone in treatment of cerebral edema associated with brain tumors. Lancet 1961 (81):46–53
Long DM, Hartmannn JF, French LA: The response of human cerebral edema to glucosteroid administration: An electron microscopic administration. Neurology 1966 (16):521–528
Shapiro WR, Posner JB: Corticosteroid hormones: Effects in an experimental brain tumor. Arch Neurol 1974 (30):217–220
Yamada K, Bremer AM, West CR: Effects of dexamethasone on tumor-induced brain edema and its distribution in the brain of monkeys. J Neurosurg 1979 (50):361–367
Fishman RA: Steroids in the treatment of brain edema. N Engl J Med 1982 (306):359–360
Yamata K, Ushio Y, Hayagawa T, Arita N, Yamada N, Mogami H: Effects of methylprednisolone on peritumoral brain edema: A quantitative autoradiographic study. J Neurosurg 1983 (59):612–619
Jarden JO, Dhawan V, Moeller JR, Strother SC, Rottenberg DA: The time course of steroid action on blood-to-brain and blood-to-tumor transport of 82Rb: A positron emission tomographic study. Ann Neurol 1989 (25):239–245
Rapoport SI: Effects of concentrated solution on blood-brain barrier. Am J Physiol 1970 (219):270–274
Rapoport SI: Quantitative aspects of osmotic opening of the blood-brain barrier. In: Weiss L, Gilbert HA, Posner JB (eds) Brain metastases. GK Hall & Co, Boston 1980 pp 100–114
Cosolo WC, Martinello P, Louis WJ, Christophidis N: Blood brain barrier disruption using mannitol: time course and electron microscopy studies. Am J Physiol 1989 (256):R443–R447
Koenig H, Goldstone AD, Lu CY, Trout JJ: Polyamines and Ca2+ mediate hyperosmolal opening of the blood-brain barrier: In vitro studies in isolated rat cerebral capillaries. J Neurochem 1989 (52) :1135–1142
Hiesiger EM, Voorhies RM, Basler GA, Lipschutz LE, Posner JB, Shapiro WR: Opening the blood brain and blood-tumor barriers in experimental rat brain tumors: The effect of intracarotid hyperosmolar mannitol on capilary permeability and blood flow. Ann Neurol 1986 (19):50–59
Warnke PC, Blasberg RG, Groothuis DR: The effect of blood-brain barrier disruption on blood-totissue transport in ENU-induced gliomas. Ann Neurol 1987 (22):300–305
Fishman RA: Is there a therapeutic role for osmotic breaching of the blood-brain barrier ? Ann Neurol 1987 (22):300–305
Suzuki M, Iwasaki Y, Yamamoto T, Konno H, Kudo H: Sequelae of the osmotic blood-brain barrier opening in rats. J Neurosurg 1988 (69):421–428
Neuwelt EA, Specht HD, Hill SA: Permeability of human brain tumor to 99mTc-glucoheptonate and 99mTc-albumin: Implications for monoclonal antibody therapy. J Neurosurg 1986 (65):194–198
Neuwelt EA, Specht D, Barnett PA, Dahlborg SA, Miley A, Larson SM, Brown P, Eckerman KF, Hellström KE, Hellström I: Increased delivery of tumor specific monoclonal antibodies to brain after osmotic blood-brain barrier modification in patients with melanoma metastatic to the central nervous system. Neurosurg 1987 (20):885–895
Neuwelt EA, Barnett PA, Hellström I, Hellström KE, Beaumier P, McCormick CI, Weigel RM: Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragments to normal brain utilizing osmotic blood-brain barrier disruption. Cancer Res 1988 (48):4725–4729
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Delattre, JY., Posner, J.B. (1990). The Blood-Brain Barrier: Morphology, Physiology and its Changes in Cancer Patients. In: Hildebrand, J. (eds) Neurological Adverse Reactions to Anticancer Drugs. ESO Monographs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76142-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-76142-3_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-76144-7
Online ISBN: 978-3-642-76142-3
eBook Packages: Springer Book Archive